SUBSCRIBE
SUBSCRIBE

Computer Modeling Aids Dose Selection for Apixaban Phase III Trials

August 17, 2010 | 
1 min read

MedWire News -- US researchers have used a model-based approach to determine the optimum dosage of apixaban for the prevention of venous thromboembolism (VTE) after total knee replacement (TKR).